These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Wijker M; Wszolek ZK; Wolters EC; Rooimans MA; Pals G; Pfeiffer RF; Lynch T; Rodnitzky RL; Wilhelmsen KC; Arwert F Hum Mol Genet; 1996 Jan; 5(1):151-4. PubMed ID: 8789453 [TBL] [Abstract][Full Text] [Related]
6. [Characteristic clinicopathological and genetic features of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): in particular consideration for a large family of pallido-ponto-nigral degeneration (PPND)]. Yamada T No To Shinkei; 1999 Sep; 51(9):761-9. PubMed ID: 10511953 [No Abstract] [Full Text] [Related]
7. Anatomy of disturbed sleep in pallido-ponto-nigral degeneration. Spector AR; Dugger BN; Wszolek ZK; Uitti RJ; Fredrickson P; Kaplan J; Boeve BF; Dickson DW; Strongosky A; Lin SC Ann Neurol; 2011 Jun; 69(6):1014-1025. PubMed ID: 21681797 [TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Slowinski J; Dominik J; Uitti RJ; Ahmed Z; Dickson DD; Wszolek ZK Neuropathology; 2007 Feb; 27(1):73-80. PubMed ID: 17319286 [TBL] [Abstract][Full Text] [Related]
9. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation. Miklossy J; Qing H; Guo JP; Yu S; Wszolek ZK; Calne D; McGeer EG; McGeer PL Acta Neuropathol; 2007 Sep; 114(3):243-54. PubMed ID: 17639429 [TBL] [Abstract][Full Text] [Related]
10. Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Wszolek ZK; Lagerlund TD; Steg RE; McManis PG Electroencephalogr Clin Neurophysiol; 1998 Sep; 107(3):213-22. PubMed ID: 9803952 [TBL] [Abstract][Full Text] [Related]
11. Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family. Kishore A; Wszolek ZK; Snow BJ; de la Fuente-Fernandez R; Arwert F; Wijker M; Schulzer M; Calne DB; Vingerhoets FJ Neurology; 1996 Dec; 47(6):1588-90. PubMed ID: 8960754 [TBL] [Abstract][Full Text] [Related]
12. Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17. Cheshire WP; Tsuboi Y; Wszolek ZK Auton Neurosci; 2002 Nov; 102(1-2):71-7. PubMed ID: 12492138 [TBL] [Abstract][Full Text] [Related]
13. Rapidly progressive autosomal dominant Parkinsonism and dementia with Pallido-Ponto-Nigral Gegeneration (PPND) and Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex (DDPAC) are clinically distinct conditions that are both linked to 17q21-22. Wszolek ZK; Lynch T; Wilhelmsen KC Parkinsonism Relat Disord; 1997 Apr; 3(2):67-76. PubMed ID: 18591058 [TBL] [Abstract][Full Text] [Related]
14. Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Wszolek ZK; Pfeiffer RF; Bhatt MH; Schelper RL; Cordes M; Snow BJ; Rodnitzky RL; Wolters EC; Arwert F; Calne DB Ann Neurol; 1992 Sep; 32(3):312-20. PubMed ID: 1416801 [TBL] [Abstract][Full Text] [Related]
15. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Frank AR; Wszolek ZK; Jack CR; Boeve BF Neurology; 2007 Feb; 68(8):620-1. PubMed ID: 17310038 [No Abstract] [Full Text] [Related]
16. Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17. van Swieten JC; Rosso SM; van Herpen E; Kamphorst W; Ravid R; Heutink P Dement Geriatr Cogn Disord; 2004; 17(4):261-4. PubMed ID: 15178932 [TBL] [Abstract][Full Text] [Related]
17. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Zarranz JJ; Ferrer I; Lezcano E; Forcadas MI; Eizaguirre B; Atarés B; Puig B; Gómez-Esteban JC; Fernández-Maiztegui C; Rouco I; Pérez-Concha T; Fernández M; Rodríguez O; Rodríguez-Martínez AB; de Pancorbo MM; Pastor P; Pérez-Tur J Neurology; 2005 May; 64(9):1578-85. PubMed ID: 15883319 [TBL] [Abstract][Full Text] [Related]
18. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Arvanitakis Z; Witte RJ; Dickson DW; Tsuboi Y; Uitti RJ; Slowinski J; Hutton ML; Lin SC; Boeve BF; Cheshire WP; Pooley RA; Liss JM; Caviness JN; Strongosky AJ; Wszolek ZK Parkinsonism Relat Disord; 2007 May; 13(4):230-9. PubMed ID: 17196872 [TBL] [Abstract][Full Text] [Related]
19. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Yasuda M; Kawamata T; Komure O; Kuno S; D'Souza I; Poorkaj P; Kawai J; Tanimukai S; Yamamoto Y; Hasegawa H; Sasahara M; Hazama F; Schellenberg GD; Tanaka C Neurology; 1999 Sep; 53(4):864-8. PubMed ID: 10489057 [TBL] [Abstract][Full Text] [Related]
20. [Tauopathies--a new class of neurodegenerative diseases]. Ludolph AC; Sperfeld A; Collatz BM; Storch A Nervenarzt; 2001 Feb; 72(2):78-85. PubMed ID: 11256158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]